x
Filter:
Filters applied
- Free Access
Publication Date
Please choose a date range between 2010 and 2020.
Author
- Johnson, Martin H18
- Cohen, Jacques14
- Alikani, Mina7
- Grudzinskas, Gedis6
- Gleicher, Norbert5
- Agarwal, Ashok4
- Benagiano, Giuseppe4
- Franklin, Sarah4
- Venetis, Christos A4
- Barbara, Giussy3
- Buggio, Laura3
- Fauser, Bart CJM3
- Frattaruolo, Maria Pina3
- Griesinger, Georg3
- Ahuja, Kamal K2
- Altmäe, Signe2
- Andersen, Claus Yding2
- Balaban, Basak2
- Barad, David H2
- Ben-Shlomo, Izhar2
- Benagiano, G2
- Bisignano, Alexander2
- Cognigni, Graciela Estela2
- Filicori, Marco2
- Garcia-Velasco, Juan A2
Keyword
- IVF28
- infertility9
- cryopreservation8
- ovarian stimulation8
- pregnancy8
- ethics6
- embryo5
- ICSI5
- meta-analysis5
- fertilization4
- Infertility4
- PGD4
- surrogacy4
- COVID-193
- HFEA3
- Ovarian hyperstimulation syndrome3
- pregnancy rate3
- Anti-Müllerian hormone2
- ART2
- Assisted reproduction2
- Diagnosis2
- Endometriosis2
- PGS2
- Polycystic ovary syndrome2
- Preimplantation genetic screening2
Free Access Articles
260 Results
- VIEWPOINT
Reproductive technology and social justice: a view from Brazil
Reproductive BioMedicine OnlineVol. 41Issue 6p1151–1153Published in issue: December, 2020- Marilena Correa
- Ilana Löwy
Cited in Scopus: 1Debates on the practical and ethical dilemmas produced by the rapid changes in assisted reproductive technology (ART) are frequently focused on the consequences of new developments in Western Europe and North America. Discussions about ART in developing and middle-income countries tend to be centred on the use – and for some, the possible exploitation – of women's bodies as sources of biological materials and providers of services. They more rarely examine patterns of implementation of ART in these countries. - EDITORIAL
Home monitoring of ovarian stimulation: an important step towards more patient-centred IVF
Reproductive BioMedicine OnlineVol. 41Issue 6p971–974Published online: October 30, 2020- J.M.R. Gerris
- B.C.J.M. Fauser
Cited in Scopus: 1Since the early 1980s there has been constant evolution in the clinical management of IVF treatments. From the patient's perspective, significant innovations have included: (i) the replacement of oocyte retrieval through laparoscopy under general anaesthesia by ultrasound-guided out-patient transvaginal puncture; (ii) the introduction of GnRH analogues to suppress a premature rise in LH (avoiding the need for frequent LH peak monitoring); (iii) calibrated pens allowing patients to inject gonadotrophins themselves and avoiding dependency on nurses or hospital facilities; (iv) the introduction of milder and less complex stimulation protocols (significantly reducing side effects and the need for intense ovarian response monitoring and frequent hospital visits) (Nargund and Fauser, 2020); and (v) the recognition of the distinct burden of treatment and psychological stress associated with IVF (resulting in significant treatment drop out and reduced cumulative pregnancy chances per started IVF treatment). - Review
Fertility preservation during the COVID-19 pandemic: mitigating the viral contamination risk to reproductive cells in cryostorage
Reproductive BioMedicine OnlineVol. 41Issue 6p991–997Published online: September 14, 2020- Satish K. Adiga
- Prathima Tholeti
- Shubhashree Uppangala
- Guruprasad Kalthur
- Roberto Gualtieri
- Riccardo Talevi
Cited in Scopus: 10Reopening fertility care services across the world in the midst of a pandemic brings with it numerous concerns that need immediate addressing, such as the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the male and female reproductive cells and the plausible risk of cross-contamination and transmission. Due to the novelty of the disease the literature contains few reports confirming an association of SARS-CoV-2 with reproductive tissues, gametes and embryos. Cryobanking, an essential service in fertility preservation, carries the risk of cross-contamination through cryogenic medium and thus calls for risk-mitigation strategies. - EDITORIAL
Reproduction, Technology and Society - a new section in RBMO
Reproductive BioMedicine OnlineVol. 41Issue 3p351Published in issue: September, 2020- N. Macklon
- S. Camporesi
- R. Vassena
- K.K. Ahuja
Cited in Scopus: 0This issue sees the launch of Reproduction, Technology and Society (RTS), a new section of RBMO fully dedicated, as the name conveys, to issues at the interfaces between reproduction, technology, and society. - Commentary
A revolutionary joins the establishment: Reproductive Biomedicine Online turns 20
Reproductive BioMedicine OnlineVol. 41Issue 6p978–980Published online: September 1, 2020- Fiona Bennett
Cited in Scopus: 0This commentary highlights the publishing revolution achieved by Robert Edwards in founding Reproductive Biomedicine Online. It corrects some inaccuracies in the account given by Roger Gosden in his recently published book Let There Be Life: An Intimate Portrait of Robert Edwards and His IVF Revolution. - Commentary
Preimplantation genetic testing as a component of root cause analysis of errors and reassignment of embryos in IVF
Reproductive BioMedicine OnlineVol. 41Issue 6p975–977Published online: August 26, 2020- Megan Bunnell
- Navid Esfandiari
Cited in Scopus: 0The risks of embryo/gamete mix-up are a threat to the integrity of the IVF process, with significant implications for affected families. The use of preimplantation genetic testing through single-nucleotide polymorphism array or next-generation sequencing technology can help to identify, characterize and ultimately help, in some cases, to find the root cause, and to mitigate the extent of these errors for a given patient or laboratory. - Letter
Strong variation in progesterone production of the placenta in early pregnancy – what are the clinical implications?
Reproductive BioMedicine OnlineVol. 41Issue 4p748–749Published online: July 17, 2020- Kay Neumann
- Marion Depenbusch
- Askan Schultze-Mosgau
- Georg Griesinger
Cited in Scopus: 4We thank Dr Tesarik (Tesarik, 2020) for his interest in our study on the onset of placental progesterone production in patients receiving dydrogesterone for scheduling endometrial receptivity and for supporting early pregnancy in anovulatory (‘artificial’) frozen-thawed embryo transfer cycles (FET) (Neumann et al., 2020). In his letter, Dr Tesarik suggests that the luteo-placental shift can be delayed and that this delay could be a cause for miscarriage. Indeed, in our study a strong variation in placental progesterone production between individual singleton pregnancies can be observed (Figure 4A, Neumann et al., 2020). - Letter
Can miscarriage caused by delayed luteoplacental shift be avoided?
Reproductive BioMedicine OnlineVol. 41Issue 4p747Published online: July 17, 2020- Jan Tesarik
Cited in Scopus: 2I read with interest the article by Neumann et al. (2020) which showed that in anovulatory frozen embryo transfer (FET) using dydrogesterone instead of progesterone for luteal phase support, a significant increase in trophoblastic progesterone production occurs 23–29 days after embryo transfer in pituitary-suppressed women. When ovarian activity is not suppressed, the onset of placental progesterone production is accompanied by luteolysis, a phenomenon known as luteoplacental shift (LPS). - CommentaryOpen Access
Empathetic application of machine learning may address appropriate utilization of ART
Reproductive BioMedicine OnlineVol. 41Issue 4p573–577Published online: July 14, 2020- Julian Jenkins
- Sheryl van der Poel
- Jan Krüssel
- Ernesto Bosch
- Scott M. Nelson
- Anja Pinborg
- and others
Cited in Scopus: 5The value of artificial intelligence to benefit infertile patients is a subject of debate. This paper presents the experience of one aspect of artificial intelligence, machine learning, coupled with patient empathy to improve utilization of assisted reproductive technology (ART), which is an important aspect of care that is under-recognized. Although ART provides very effective options for infertile patients to build families, patients often discontinue ART when further treatment is likely to be beneficial and most of these patients do not achieve pregnancy without medical aid. - EDITORIAL
Meet our new editor: Professor Laura Rienzi
Reproductive BioMedicine OnlineVol. 41Issue 3p352Published online: July 5, 2020Cited in Scopus: 0Laura Rienzi is a Senior Clinical Embryologist and Laboratory Director at the GENERA Centres for Reproductive Medicine in Rome, Marostica, Umbertide and Naples in Italy. Laura has academic degrees in biology from the University of Rome 'La Sapienza' and in reproductive medicine from the University of Padua. Since 2016, she has been adjunct Professor of Biotechnology at the University of Urbino, Italy. - Commentary
Reproductive healthcare during a pandemic: a New York state of mind
Reproductive BioMedicine OnlineVol. 41Issue 3p370–372Published online: June 16, 2020- Vitaly A. Kushnir
- Banafsheh Kashani
- Eli Y. Adashi
Cited in Scopus: 1The purpose of this Commentary is to assess whether the designation by New York State Department of Health of ‘sexual and reproductive health services as essential’ is consonant with the seemingly divergent objectives of providing patient-centred care and advancing national public health objectives in the resource-constrained setting of a global pandemic. - commentary
Trends in ovarian hyperstimulation syndrome hospitalization rates in the USA: an ongoing concern
Reproductive BioMedicine OnlineVol. 41Issue 3p357–360Published online: June 15, 2020- Keren Rotshenker-Olshinka
- Ahmad Badeghiesh
- Alexander Volodarsky-Perel
- Naama Steiner
- Eva Suarthana
- Michael H Dahan
Cited in Scopus: 8Ovarian hyperstimulation syndrome (OHSS) is a serious, almost exclusively, iatrogenic complication of ovarian stimulation. Many techniques have been developed over the past 25 years to decrease OHSS risks, and most have been in common use for 15–20 years. In view of these techniques, it could be hypothesized that severe OHSS rates would decrease or almost disappear. According to the US National ART Surveillance System, rates did not change significantly between 2000 and 2009, at 106 OHSS cases per 10,000 IVF cycles annually. - Commentary
SARS-CoV-2: diagnostic and design conundrums in the context of male factor infertility
Reproductive BioMedicine OnlineVol. 41Issue 3p365–369Published online: June 2, 2020- Gulam Bahadur
- Santanu Acharya
- Asif Muneer
- Judith Huirne
- Mariusz Łukaszuk
- Pablo Alexis Doreski
- and others
Cited in Scopus: 6The question of whether SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus-2 [SARS-CoV-2], leading to the COVID-19 infection) can be harboured in the testes and/or semen is currently unanswered. It is essential to understand the limitations of both antibody and real-time PCR tests in interpreting SARS-CoV-2 data in relation to analyses of semen and testicular tissue without appropriate controls. This article critically analyses the evidence so far on this, and the possible implications. - Editorial
Mild ovarian stimulation for IVF is the smartest way forward
Reproductive BioMedicine OnlineVol. 41Issue 4p569–571Published online: May 22, 2020- G. Nargund
- B.C.J.M. Fauser
Cited in Scopus: 21The aim of IVF treatment is to achieve a healthy full-term baby, with minimal health risks to the woman and her child, and at reasonable cost to allow this treatment option to be within financial reach for many women around the world. Ovarian stimulation – which contributes a considerable proportion of the overall cost of IVF – aims to generate multiple follicle development, allowing for the retrieval of multiple oocytes to improve success rates. Complex ovarian stimulation regimens have become an integral part of most IVF programmes. - Commentary
Generating translatable evidence to improve patient care: the contribution of human factors
Reproductive BioMedicine OnlineVol. 41Issue 3p353–356Published online: May 10, 2020- Masoud A.M. Afnan
- Khalid Saeed Khan
- Ben Willem Mol
Cited in Scopus: 4Generating translatable evidence to improve patient care has proved challenging in reproductive medicine, with many ‘add-on’ treatments in routine assisted conception clinical practice that have not been reliably tested. This has consequences for patient care; specifically, IVF pregnancy rates have not improved. A change of culture is required in our profession, from indiscriminately applying the latest ‘add-on’ to large-scale participation in generating reliable translatable evidence. - Editorial
Male fertility: a window on the health of this generation and the next
Reproductive BioMedicine OnlineVol. 39Issue 5p721–723Published online: September 24, 2019- Christopher LR Barratt
- Richard A Anderson
- Chris De Jonge
Cited in Scopus: 0In this issue of RBMO Martín-Calvo and colleagues (Martín-Calvo et al., 2019) provide clinical data showing that higher paternal pre conception folate intake was significantly associated with a longer gestation time. Previous studies in mice have shown that manipulation of paternal dietary folate was associated with increased birth defects and identified marked changes in the sperm epigenome associated with health of the offspring (Lambrot et al., 2013). Whilst the potential epigenetic mechanisms remain to be elucidated fully in animals and are, at best, unclear in humans, this study puts the focus of examination on the contribution of the male to overall health of future generations. - Editorial
May the colleague who truly has no conflict of interest now please stand up!
Reproductive BioMedicine OnlineVol. 39Issue 4p541–544Published online: September 7, 2019- Bart C.J.M. Fauser
- N.S. Macklon
Cited in Scopus: 4A vividly remembered conversation from quite a few years ago with someone influential in Dutch society began ‘I am sure you academics do very important scientific work, but the problem is that we as society notice so little health benefits resulting from these discoveries. Since universities are primarily paid by tax payers' money, what's our return on this investment?’ It took quite some time to get to grips with this message, but it did lead to the profound realization of how far away from mainstream society we often operate. - Review
Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 39Issue 5p751–763Published online: July 3, 2019- Belinda G. Vermey
- Su Jen Chua
- Mohammad Hadi Zafarmand
- Rui Wang
- Salvatore Longobardi
- Evelyn Cottell
- and others
Cited in Scopus: 26The aim of assisted reproduction technology (ART) is to help an infertile couple have a healthy baby born at term. Multifollicular growth induced by ovarian stimulation can lead to the collection of multiple oocytes, which, in turn, seems to increase pregnancy chances after ART. Hence, clinicians have for years been trying to obtain an adequate number of oocytes while minimizing the risk of ovarian hyperstimulation syndrome. Some have advocated that a higher number of collected oocytes is associated with improved outcomes (Baker et al., 2015; Macklon et al., 2006; van der Gaast et al., 2006). - Editorial
The female post-cancer fertility-counselling clinic: looking beyond the freezer. A much needed addition to oncofertility care
Reproductive BioMedicine OnlineVol. 39Issue 2p179–181Published online: May 29, 2019- Kirsten Tryde Macklon
- Bart CJM Fauser
Cited in Scopus: 9The number of girls and young women surviving cancer is increasing. It has been estimated that each year 43 new cancer cases are diagnosed per 100,000 people of both sexes between the ages of 20 and 39 years. Cancer is more common in women than men (Fidler et al, 2017). The consequences of being diagnosed with a malignant disease are serious, not just for the individual but also at a societal and economic level. While treatment is often successful, the impact of the disease on the life course is significant, as multiple long-term side effects of cancer treatment, and the psychological fallout of facing such a diagnosis at a young age, continue to resonate in later life. - Commentary
Advanced fibroid study: paying homage to John Sampson
Reproductive BioMedicine OnlineVol. 39Issue 2p183–186Published online: April 25, 2019- John L Yovich
- Philip K Rowlands
- Sunthra Lingam
- Mark Sillender
- Shanthi Srinivasan
Cited in Scopus: 3A recent article supports our longstanding view that all intramural fibroids can cause disturbance of uterine function. This may be reflected in the symptom of menorrhagia or fertility-related issues, as well as pregnancy losses at all gestational stages. However, it was disappointing that there was no reference to either the mechanism by which fibroids disturb uterine function nor to the gynaecologist who described this more than 100 years ago, namely John Sampson. In fact, Sampson's findings about the unique venous drainage mechanism from the endometrium explains how menstrual loss is contained in normal physiology, but which can be excessive when the protective ‘anaemic’ zone is disturbed. - Review
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 39Issue 2p332–342Published online: April 25, 2019- Yi Han
- Yingjie Li
- Bing He
Cited in Scopus: 51This meta-analysis aimed to evaluate the efficacy and safety of glucagon-like peptide 1 (GLP-1) receptor agonists for women with polycystic ovary syndrome (PCOS) by comparing their effect with that of metformin. Electronic databases (PubMed, EMBASE, Cochrane Library, WanFang Database, CNKI) dating from their establishment to June 2018 were searched to find all randomized controlled trials (RCTs) reporting the efficacy of GLP-1 receptor agonists versus metformin for patients with PCOS. Therapeutic variables included menstrual cycle, sex hormone and clinical manifestations, glucose metabolism and other metabolic indexes. - Review
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
Reproductive BioMedicine OnlineVol. 39Issue 2p321–331Published online: March 29, 2019- Antonio La Marca
- Martina Capuzzo
Cited in Scopus: 29Advances in oocyte and embryo cryopreservation for assisted reproduction prompted new approaches to ovarian stimulation. Attention has been paid to progesterone and its derivatives to block the LH surge, as oocyte vitrification removes possible harmful effects of progestins on endometrial receptivity. This review summarizes the current status of progestin use to inhibit ovulation during ovarian stimulation compared with conventional ovarian stimulation. Progestin-primed ovarian stimulation is shown to effectively inhibit spontaneous ovulation, without affecting the number of retrieved oocytes and embryo quality. - Review
A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF
Reproductive BioMedicine OnlineVol. 39Issue 2p281–293Published online: March 28, 2019- Tingting Sha
- Xiaojuan Wang
- Wenwei Cheng
- Yan Yan
Cited in Scopus: 69Polycystic ovary syndrome (PCOS) is one of the most common and complex hormonal disorders seen in women and is considered to be a significant public health issue (Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004). PCOS has a negative effect on women's health across the lifespan, leading to, for example, anxiety, depression, insulin resistance, abdominal obesity, hypertension and dyslipidaemia (Teede et al., 2010); it is also an important cause of infertility in women of reproductive age because of the associated anovulation (Homburg and Crawford, 2014). - Editorial
Chief editor’s 2018 annual report
Reproductive BioMedicine OnlineVol. 38Issue 5p655–658Published online: March 19, 2019- Bart CJM Fauser
- Kamal K Ahuja
Cited in Scopus: 1We have completed yet another exciting year at RBMO. Most importantly the broad scope of the journal's content and the close interaction between the editorial office staff and the editors and the authors remains a constant strength. In addition, we completely updated the layout of the journal: both the artwork and logo on the cover and also the layout of the papers themselves. We are very proud of the new look and feel of RBMO, which is now completely in line with the identity of the journal, the growth of the field and our level of ambition! During summer, the editorial office moved to Bourn Hall, Cambridge, UK, a most fitting location. - REVIEW
Influence of oral vitamin and mineral supplementation on male infertility: a meta-analysis and systematic review
Reproductive BioMedicine OnlineVol. 39Issue 2p269–279Published online: March 16, 2019- Kai Buhling
- Annika Schumacher
- Christine zu Eulenburg
- Elena Laakmann
Cited in Scopus: 30This meta-analysis and systematic review investigated evidence of the effect of oral micronutrient supplementation on male fertility. Following searches of PubMed, Ovid/Ovid Medline(r) and Embase, 18 randomized, double-blind, placebo-controlled trials were included in the meta-analysis (seven studies) and/or the systematic review (12 studies). The meta-analysis showed significant improvement in semen parameters for selenium (200µg/day and 100µg/day) (standard mean difference [SMD] 0.64 for oligozoospermia, 1.39 for asthenozoospermia), L-carnitine (2 g/day) and acetyl-L-carnitine (LAC; 1 g/day) combined (SMD 0.57 for asthenozoospermia), and co-enzyme Q10 (200 and 300 mg/day) (SMD 0.95 for oligozoospermia, 1.48 for asthenozoospermia, 0.63 for teratozoospermia). - Editorial
Origins of mosaicism and criteria for the transfer of mosaic embryos
Reproductive BioMedicine OnlineVol. 36Issue 4p369–370Published in issue: April, 2018- Santiago Munné
Cited in Scopus: 7Blastocysts classified as mosaic by preimplamtation genetic testing for aneuploidy (PGT-A) [usually through array comparative genomic hybridization (aCGH) or next-generation sequencing (NGS)] have been reported to implant less frequently and miscarry more frequently than embryos classified as euploid, but still be able to produce chromosomally normal and viable pregnancies (Fragouli et al., 2017; Greco et al., 2015; Munné et al., 2017; Spinella et al., 2018). As such, the Preimplantation Genetic Diagnosis International Society (PGDIS), Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN) and others (Munné et al., 2016) have recommended that care providers prioritize euploid embryos over mosaic embryos for transfer and only consider mosaics for replacement when no euploid embryos are available. - Mini-Review
Imaging the ovary
Reproductive BioMedicine OnlineVol. 36Issue 5p584–593Published online: March 6, 2018- Yi Feng
- Amin Tamadon
- Aaron J.W. Hsueh
Cited in Scopus: 12Using mainly histological analyses of fixed ovarian tissues and ultrasound imaging of ovaries in vivo, earlier imaging studies have established the basic framework of ovarian folliculogenesis as well as luteal formation and regression. The ovary contains individual follicles as functional structures, together with corpora lutea, interstitial tissues, innermost medulla and the outmost layer of the surface epithelium. Most of the 800,000 primordial follicles found at birth in human females remain at the dormant stage. - Editorial
Chief editor's 2017 annual report
Reproductive BioMedicine OnlineVol. 36Issue 3p245–249Published in issue: March, 2018- Bart C.J.M. Fauser
- Kamal K. Ahuja
Cited in Scopus: 22017 was an exciting and rewarding year for RBM Online, as it continued to provide cutting-edge information regarding basic, translational and clinical aspects of infertility and related areas of reproductive health. Among the successes, most notably the impact factor reached a value well above 3 for the first time in the journal's history (Figure 1), placing it in the first quartile of all journals published in the categories ‘Obstetrics and Gynecology’ and ‘Reproductive Biology’. - Review
Can time-lapse parameters predict embryo ploidy? A systematic review
Reproductive BioMedicine OnlineVol. 36Issue 4p380–387Published online: February 1, 2018- Arnaud Reignier
- Jenna Lammers
- Paul Barriere
- Thomas Freour
Cited in Scopus: 41Embryo morphology assessment performs relatively poorly in predicting implantation. Embryo aneuploidy screening (PGS) has recently improved, but its clinical value is still debated, and the development of a cheap non-invasive method for the assessment of embryo ploidy status is a highly desirable goal. The growing implementation of time-lapse devices led some teams to test the effectiveness of morphokinetic parameters as predictors of embryo ploidy, with conflicting results. The aim of this study was to conduct a comprehensive review of the literature on the predictive value of morphokinetic parameters for embryo ploidy status. - Commentary
A demographic projection of the contribution of assisted reproductive technologies to world population growth
Reproductive BioMedicine OnlineVol. 36Issue 4p455–458Published online: February 1, 2018- Malcolm J. Faddy
- Matthew D. Gosden
- Roger G. Gosden
Cited in Scopus: 49Enormous unmet needs for infertility treatment exist because access to assisted reproductive technologies is demographically skewed. Since the first IVF baby in 1978, the number of people conceived by reproductive technology has grown much faster than expected, reaching several million today and rapidly approaching 0.1% of the total world population. As more patients build families, and their children in turn become parents, the number owing their existence to assisted reproductive technologies, either directly or indirectly, will expand tremendously in future decades, but no attempts have been made hitherto to project the magnitude. - Review
Multiple pregnancies achieved with IVF/ICSI and risk of specific congenital malformations: a meta-analysis of cohort studies
Reproductive BioMedicine OnlineVol. 36Issue 4p472–482Published online: February 1, 2018- Zan Zheng
- Letao Chen
- Tubao Yang
- Hong Yu
- Hua Wang
- Jiabi Qin
Cited in Scopus: 18Studies comparing risk of specific congenital malformations (CM) between multiple pregnancies resulting from IVF/intracytoplasmic sperm injection (ICSI) and those conceived naturally report conflicting results; furthermore, there is a lack of a complete overview. This meta-analysis aimed to address which types of CM are increased in IVF/ICSI multiple pregnancies compared with those conceived naturally. All studies testing the association between IVF/ICSI multiple pregnancies and specific CM identified in various databases were considered. - Review
Effect of male body mass index on assisted reproduction treatment outcome: an updated systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 36Issue 4p459–471Published online: January 23, 2018- Rabia Mushtaq
- Jyotsna Pundir
- Chiara Achilli
- Osama Naji
- Yacoub Khalaf
- Tarek El-Toukhy
Cited in Scopus: 46Men with a body mass index (BMI) of 30 or over are more likely to have reduced fertility and fecundity rates. This systematic review and meta-analysis evaluated the effect of male BMI on IVF and intracytoplasmic sperm injection (ICSI) outcome. An electronic search for published literature was conducted in MEDLINE and EMBASE between 1966 and November 2016. Outcome measures were clinical pregnancy rates (CPR) and live birth rates (LBR) per IVF or ICSI cycle. Eleven studies were identified, including 14,372 cycles; nine reported CPR and seven reported LBR. - Review
Follicular flushing in patients with poor ovarian response: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 36Issue 4p408–415Published online: December 29, 2017- Kay Neumann
- Georg Griesinger
Cited in Scopus: 11A systematic literature review and meta-analysis was conducted to evaluate the effect of follicular flushing on clinical outcomes (primary outcome: mean number of cumulus–oocyte–complexes [COC]) in poor-response IVF patients). The bibliographic databases OvidMedline (includes Pubmed), Cochrane Library and Web of Science were searched electronically for randomized controlled trials (RCT) comparing follicular flushing with no flushing. Three RCT with a total of 210 patients could be included. The mean number of COC did not increase with flushing (weighted mean difference: −0.45 COC, 95% CI −1.14 to 0.25, I2 = 70%; P = 0.21; three RCT, n = 210). - Review
A search for molecular mechanisms underlying male idiopathic infertility
Reproductive BioMedicine OnlineVol. 36Issue 3p327–339Published online: December 27, 2017- An Bracke
- Kris Peeters
- Usha Punjabi
- David Hoogewijs
- Sylvia Dewilde
Cited in Scopus: 109Infertility affects approximately 15% of the couples wanting to conceive. In 30 − 40% of the cases the aetiology of male infertility remains unknown and is called idiopathic male infertility. When assisted reproductive technologies are used to obtain pregnancy, an adequate (epi)genetic diagnosis of male infertility is of major importance to evaluate if a genetic abnormality will be transmitted to the offspring. In addition, there is need for better diagnostic seminal biomarkers to assess the success rates of these assisted reproductive technologies. - Editorial
Surging ahead
Reproductive BioMedicine OnlineVol. 36Issue 1p4–5Published online: December 13, 2017- Bart Fauser
- Mina Alikani
- Richard Anderson
- Sarah Franklin
- Martin H. Johnson
- Juan Garcia Velasco
Cited in Scopus: 12017 was a very successful year for RBMOnline, most notably with the announcement of an Impact Factor of 3.249, the highest yet achieved by the journal since its inclusion in the ranking nearly 10 years ago, and matched by improvements in other ranking metrics such as CiteScore, Article Influence and SNIP. This outcome reflects the increased quality of the papers published in the journal and places it in sixth position in the ranking of reproductive biology titles. As part of the continuing development of the journal, we welcomed Richard Anderson to the team of editors (Anderson, 2017), joining Mina Alikani, Juan Garcia Velasco and Martin Johnson, and allowing the Chief Editor more time to focus on strategic considerations. - Review
Role of Withania somnifera (Ashwagandha) in the management of male infertility
Reproductive BioMedicine OnlineVol. 36Issue 3p311–326Published online: December 7, 2017- Pallav Sengupta
- Ashok Agarwal
- Maria Pogrebetskaya
- Shubhadeep Roychoudhury
- Damayanthi Durairajanayagam
- Ralf Henkel
Cited in Scopus: 45To manage male infertility caused by hormonal imbalance, infections and other predicaments, multifarious treatment strategies are emerging worldwide. Contemporary treatments, such as assisted reproductive techniques, are costly with low success rates of only 10–30%; however, herbal remedies are gaining more attention as an alternative or supplementary therapeutic modality for male infertility. The beneficial effects induced by oral intake of the roots of a small evergreen shrub, Withania sominifera (Ashwagandha) on semen quality of infertile men have previously been studied. - Commentary
Dignity again
Reproductive BioMedicine OnlineVol. 36Issue 3p285–287Published online: December 7, 2017- Alain Pottage
Cited in Scopus: 4Two recent contributions to this journal discuss a challenge to Stanford's time-lapse embryo monitoring patent, currently before the European Patent Office (EPO). Sterckx, Cockbain and Pennings (2017) would like to keep the morphokinetics of embryo division in the public domain; they argue that time-lapse monitoring (TLM) is a diagnostic method in the sense of European patent law and therefore unpatentable. In response, Pearce (2017) suggests that the jurisprudence of the EPO unambiguously says that TLM is not a diagnostic method. - Review
Risk of pelvic inflammatory disease after intrauterine insemination: a systematic review
Reproductive BioMedicine OnlineVol. 36Issue 2p164–171Published online: November 24, 2017- Roberto Matorras
- Kristian Rubio
- María Iglesias
- Itziar Vara
- Antonia Expósito
Cited in Scopus: 7The aim of this study was to ascertain the incidence of pelvic inflammatory disease (PID) after intrauterine insemination (IUI). A systematic review was conducted using three different approaches: a search of IUI registries; a search of published meta-analyses; and a search of prospective randomized trials. Search terms were ‘IUI’, ‘complications’, ‘infection’ and ‘PID’. Two IUI registers were identified that met the inclusion criteria, totalling 365,874 cycles, with 57 PID cases being reported. - Article
The uterine fibroid/myoma tumour: analysis of the global research architecture using density-equalizing mapping
Reproductive BioMedicine OnlineVol. 36Issue 2p227–238Published online: November 15, 2017- Dörthe Brüggmann
- Frank Louwen
- Tatjana Braun
- Doris Klingelhöfer
- Jan Bauer
- Michael H. Bendels
- and others
Cited in Scopus: 5Uterine fibroids can severely impact a woman’s quality of life, result in significant morbidity and are a leading indication for hysterectomy. Many aspects of the disease remain largely obscure. Despite these knowledge gaps, no detailed maps of the global fibroid research architecture have yet been generated. This study used the NewQIS approach to assess worldwide research productivity, encompassing numerous aspects of the scientific output, quality and socioeconomic features. Regression analysis indicated an increase in fibroid research activity in the investigated time periods. - Review
Progress in the diagnosis and management of adolescent endometriosis: an opinion
Reproductive BioMedicine OnlineVol. 36Issue 1p102–114Published online: October 25, 2017- Giuseppe Benagiano
- Sun-Wei Guo
- Patrick Puttemans
- Stephan Gordts
- Ivo Brosens
Cited in Scopus: 30Until recently, adolescent endometriosis has been considered a rare, often transient, condition not particularly serious for the young patient. Against this background, and not without disagreement by some, we have pointed out that early onset endometriosis (EOE) may at times be severe, necessitating quick diagnosis and proper treatment (Brosens et al., 2013b, 2014). To substantiate this viewpoint, we carefully searched published research, including some early paediatric research, and identified peritoneal reflux from neonatal uterine bleeding (NUB) occurring in 3–5% of female neonates, as a biologically plausible and likely cause of EOE (Brosens and Benagiano, 2013, 2016; Brosens et al., 2013a; Gargett et al., 2014). - Review
Insights from clinical experience in treating IVF poor responders
Reproductive BioMedicine OnlineVol. 36Issue 1p12–19Published online: October 25, 2017- Kelly J. Gonda
- Alice D. Domar
- Norbert Gleicher
- Richard P. Marrs
Cited in Scopus: 25‘Poor responders’ is a term used to describe a subpopulation of IVF patients who do not respond well to ovarian stimulation with gonadotrophins. While there is no standard definition of a poor responder, these patients tend to be of advanced maternal age (≥40 years), have a history of poor ovarian response with conventional stimulation protocols, and/or have low ovarian reserve. Despite the heterogeneity of this patient group, there are characteristics and needs common to many poor responders that can be addressed through a holistic approach. - Commentary
Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women
Reproductive BioMedicine OnlineVol. 36Issue 1p84–87Published online: October 23, 2017- Angelos Daniilidis
- George Pados
Cited in Scopus: 7According to ESHRE recommendations for women with stage I/II endometriosis, if a decision is made to proceed to laparoscopy then operative laparoscopy (excision or ablation of the endometriotic lesions) should be performed rather than only diagnostic laparoscopy, to increase ongoing pregnancy rates. Also, for infertile women with stage I/II endometriosis doctors may consider complete surgical removal of endometriosis to improve live birth rate prior to assisted reproductive treatment. This last recommendation is not well established. - Commentary
Extragonadal primordial germ cells or placental progenitor cells?
Reproductive BioMedicine OnlineVol. 36Issue 1p6–11Published online: October 13, 2017- Karen M. Downs
Cited in Scopus: 3Primordial germ cells (PGCs), the precursors of the gametes, are now claimed to segregate within the extra-embryonic tissues of three species of placental mammals. In this brief Commentary, I raise the question of whether the so-called PGCs are not PGCs at all, but rather, progenitor cells that build the fetal–placental interface in Placentalia. - Commentary
GnRHa trigger and luteal coasting: a new approach for the ovarian hyperstimulation syndrome high-risk patient?
Reproductive BioMedicine OnlineVol. 36Issue 1p75–77Published online: October 13, 2017- Barbara Lawrenz
- Peter Humaidan
- Shahar Kol
- Human M. Fatemi
Cited in Scopus: 9Final oocyte maturation using gonadotrophin-releasing hormone agonist (GnRHa) is increasingly common as it almost eliminates the risk of developing ovarian hyperstimulation syndrome (OHSS) in high-responder patients. The first studies using this approach showed a poor reproductive outcome when only vaginal progesterone was used as luteal phase support, due to the luteolysis that will develop as a result of LH withdrawal. Timely luteal administration of human chorionic gonadotrophin (HCG) will counterbalance the low LH concentrations and therefore maintain progesterone production from the corpora lutea, however, some patients with a high number of follicles will develop OHSS using this approach. - Review
Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 36Issue 1p94–101Published online: October 10, 2017- Mohan Shashikant Kamath
- Richard Kirubakaran
- Mariano Mascarenhas
- Sesh Kamal Sunkara
Cited in Scopus: 37Pregnancies resulting from assisted reproductive techniques are at higher risk of adverse perinatal outcomes compared with spontaneous conceptions. Underlying infertility and IVF procedures have been linked to adverse perinatal outcomes. It is important to know if ovarian stimulation influences perinatal outcomes after IVF. A systematic search for relevant studies was conducted up to November 2016 on the following databases: PubMed, EMBASE, DARE and Cochrane Central Register of Controlled Trials. - Commentary
A clinical assay for reactive oxygen species – ready for primetime?
Reproductive BioMedicine OnlineVol. 36Issue 1p88–89Published online: October 5, 2017- Christopher J. De Jonge
Cited in Scopus: 1Reactive oxygen species (ROS) have been demonstrated to have damaging effects on human sperm function. The measurement of ROS as an adjunct to traditional semen analysis has clinical relevance as part of the diagnosis of male infertility. The assay best suited to the clinical laboratory environment for detecting ROS generation remains somewhat controversial. A recent report on a multicenter study evaluating the reduction of nitroblue tetrazolium (NBT) to formazan precipitate as an indirect reporter of ROS-generating activity in spermatozoa, seminal plasma and semen has received a critique raising questions as to the sensitivity and specificity of the assay for detecting ROS. - Commentary
Chimeras intended for human gamete production: an ethical alternative?
Reproductive BioMedicine OnlineVol. 35Issue 4p387–390Published online: July 18, 2017- César Palacios-González
Cited in Scopus: 4Human eggs for basic, fertility and stem-cell research are in short supply. Many experiments that require their use cannot be carried out at present, and, therefore, the benefits that could emerge from these are either delayed or never materialise. This state of affairs is problematic for scientists and patients worldwide, and it is a matter that needs our attention. Recent advances in chimera research have opened the possibility of creating human/non-human animal chimeras intended for human gamete production (chimeras-IHGP). - Editorial
Human-animal chimeras: circumventing rather than discussing ethical concerns comes at a price
Reproductive BioMedicine OnlineVol. 35Issue 4p341–342Published online: July 18, 2017- Wybo Dondorp
- Martin H. Johnson
Cited in Scopus: 2This issue of RBMOnline features a highly interesting paper on chimeras intended for human gamete production by philosopher César Palacios-González (2017). The paper breaks new ground by linking two ethically charged scientific developments. Whilst several groups are aiming to create stem cell-derived gametes through tissue culture in the laboratory (Hendriks et al., 2015), others are working on interspecies chimeras as a possible future route to obtaining human stem cell-derived organs from animals, both for research and for transplantation purposes. - ReviewOpen Access
Paving the way for a gold standard of care for infertility treatment: improving outcomes through standardization of laboratory procedures
Reproductive BioMedicine OnlineVol. 35Issue 4p391–399Published online: July 14, 2017- William Schoolcraft
- Marcos Meseguer
- The Global Fertility Alliance
Cited in Scopus: 12Infertility affects over 70 million couples globally. Access to, and interest in, assisted reproductive technologies is growing worldwide, with more couples seeking medical intervention to conceive, in particular by IVF. Despite numerous advances in IVF techniques since its first success in 1978, almost half of the patients treated remain childless. The multifactorial nature of IVF treatment means that success is dependent on many variables. Therefore, it is important to examine how each variable can be optimized to achieve the best possible outcomes for patients. - Review
Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials
Reproductive BioMedicine OnlineVol. 35Issue 5p529–535Published online: July 14, 2017- Nicolás Mendoza
- Laura Pérez
- Tommaso Simoncini
- Alessandro Genazzani
Cited in Scopus: 20Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysfunction and reproductive difficulty, as well as metabolic problems. Use of the Rotterdam criteria will probably increase its already high prevalence, and currently, it is the most common endocrinopathy in women, affecting 7–14% of women of childbearing age worldwide (Bozdag et al., 2016). - Review
Pathogenesis of adenomyosis: an update on molecular mechanisms
Reproductive BioMedicine OnlineVol. 35Issue 5p592–601Published online: June 27, 2017- Silvia Vannuccini
- Claudia Tosti
- Francisco Carmona
- S. Joseph Huang
- Charles Chapron
- Sun-Wei Guo
- and others
Cited in Scopus: 141Adenomyosis is a uterine disorder becoming more commonly diagnosed in women of reproductive age because of diagnostic imaging advancements. The new epidemiological scenario and the clinical evidence of pelvic pain, abnormal uterine bleeding and infertility are changing the classic perspective of adenomyosis as a premenopausal disease. In the last decade, the evaluation of multiple molecular mediators has improved our knowledge of pathogenic mechanisms of adenomyosis, supporting that this is an independent disease from endometriosis. - Review
‘Money for nothing’. The role of robotic-assisted laparoscopy for the treatment of endometriosis
Reproductive BioMedicine OnlineVol. 35Issue 4p435–444Published online: May 30, 2017- Nicola Berlanda
- Maria Pina Frattaruolo
- Giorgio Aimi
- Marilena Farella
- Giussy Barbara
- Laura Buggio
- and others
Cited in Scopus: 12During the last decades, laparoscopic surgery has been accepted as the technique of choice for the treatment of endometriosis, because it provides long-term outcomes comparable to those achieved by laparotomy, with the established advantages of a minimally invasive technique, including better visualization, shorter hospital stay, faster recovery and better cosmetic results (Adamson et al., 1992; Daraï et al., 2010; Luciano et al., 1992; Vercellini et al., 2003). - Editorial
First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation
Reproductive BioMedicine OnlineVol. 34Issue 4p333–336Published in issue: April, 2017- Mina Alikani
- Bart C.J. Fauser
- Juan Antonio García-Valesco
- Joe Leigh Simpson
- Martin H. Johnson
Cited in Scopus: 43In this issue, Zhang et al. (2017) report the birth of a healthy boy after mitochondrial replacement therapy (MRT) by spindle transfer to prevent transmission of mitochondrial disease from mother to child. The case was first publicized in the lay press (Hamzelou, 2016; see also editorial by Johnson, 2016) and then presented during the 2016 Annual Meeting of the American Society for Assisted Reproduction (ASRM) in October 2016 (Zhang et al., 2016a). It followed an earlier report of an unsuccessful attempt at MRT by pronuclear transfer by the same group (Zhang et al., 2016b). - Article
Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment
Reproductive BioMedicine OnlineVol. 34Issue 6p557–566Published online: March 21, 2017- Chloë De Roo
- Sylvie Lierman
- Kelly Tilleman
- Karen Peynshaert
- Kevin Braeckmans
- Mirte Caanen
- and others
Cited in Scopus: 86Female-to-male transgender people (trans men), are faced with the risk of losing their reproductive potential owing to gender affirming hormone treatment and genital reconstructive surgery. Transgender people also tend to start sex reassignment treatment at a young age, when reproductive wishes are not yet clearly defined nor fulfilled (De Sutter, 2001). About one-half of trans men, however, express the desire to have children (Wierckx et al., 2012). It is, therefore, recommended by the most recent Standards of Care of the World Professional Association for Transgender Health to clearly discuss fertility and fertility preservation before any treatment (Coleman et al., 2012). - Review
Anti-Müllerian hormone kinetics in pregnancy and post-partum: a systematic review
Reproductive BioMedicine OnlineVol. 34Issue 5p522–533Published online: February 23, 2017- Sarah McCredie
- William Ledger
- Christos A. Venetis
Cited in Scopus: 9The aim of this systematic review is to critically appraise the available evidence regarding the kinetics of anti-Müllerian hormone (AMH) during pregnancy and post-partum. A systematic literature search was conducted in MEDLINE, Embase, CENTRAL, Scopus and Web of Science on 14 December 2015, aiming to identify studies providing data on the serum concentration of AMH in women at various stages of gestation and post-partum. There was a total of 1719 participants across eight studies. Seven out of the eight studies reported a decline in serum AMH concentration with advancing gestational age. - Review
Ovarian stimulation protocols for IVF: is more better than less?
Reproductive BioMedicine OnlineVol. 34Issue 4p345–353Published online: January 24, 2017- Michael M. Alper
- Bart C. Fauser
Cited in Scopus: 37Conventional ovarian stimulation protocols for IVF are designed to achieve maximum oocyte yields. Conventional protocols, however, are associated with patient discomfort, increased risk of ovarian hyperstimulation syndrome and higher costs. In recent years, mild stimulation protocols have risen in popularity. These protocols typically use lower doses (≤150 IU/day), shorter duration of exogenous gonadotrophins, or both, compared with conventional protocols, with the goal of limiting the number of retrieved oocytes to less than eight. - Review
Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity
Reproductive BioMedicine OnlineVol. 34Issue 4p422–428Published online: January 24, 2017- B Lawrenz
- HM Fatemi
Cited in Scopus: 47The premature rise of progesterone during the late follicular phase in stimulated IVF cycles is a frequent event, and emerging evidence shows that premature progesterone rise does negatively affect the outcome of assisted reproductive techniques. The effect of elevated peripheral progesterone levels in the late follicular phase seems to be on the endometrium and the window of implantation, which may lead to asynchrony between the endometrium and the developing embryo. In stimulated cycles, endometrial maturation is advanced on the day of oocyte retrieval, and patients with a progesterone level above 1.5 ng/ml on the day of final oocyte maturation have different endometrial gene expression profiles. - Review
Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 34Issue 4p383–391Published online: January 17, 2017- Chun Yang
- Jing Cai
- Yuhong Geng
- Ying Gao
Cited in Scopus: 22In this systematic review and meta-analysis, the effectiveness and safety among different dosage of methotrexate protocols for the treatment of unruptured tubal ectopic pregnancy was evaluated. Six studies of randomized contorlled trials were identified through searches conducted on PubMed, Embase and Cochrane Library between January 1974 and March 2016. The overall success rate of multiple-dose protocol was similar to the single-dose protocol (RR 1.07, 95% CI 0.99 to 1.17, I2 = 0%). The difference between double-dose and single-dose groups was not significant (RR 1.09, 95% CI 0.98 and 1.20, I2 = 0%). - Commentary
Counselling considerations for chromosomal mosaicism detected by preimplantation genetic screening
Reproductive BioMedicine OnlineVol. 34Issue 4p369–374Published online: January 14, 2017- Andria G. Besser
- Emily L. Mounts
Cited in Scopus: 32The evolution of preimplantation genetic screening (PGS) for aneuploidy to blastocyst biopsy and more sensitive 24-chromosome screening techniques has resulted in a new diagnostic category of PGS results: those classified as mosaic. This diagnosis presents significant challenges for clinicians in developing policies regarding transfer and storage of such embryos, as well as in providing genetic counselling for patients prior to and following PGS. Given the high frequency of mosaic PGS results and the wide range of possible associated outcomes, there is an urgent need to understand how to appropriately counsel patients regarding such embryos. - Obituary
Obituary: Robert A Godke Jr (1945–2015)
Reproductive BioMedicine OnlineVol. 32Issue 1p12–13Published in issue: January, 2016- The LSU Repro Rangers
Cited in Scopus: 0Robert A Godke Jr (“Bob”), Louisiana State University Boyd Professor, passed away on 8 October, 2015 after a valiant battle with pancreatic cancer. Professor Godke leaves an extraordinary legacy at LSU and around the world. Over the course of his 40-year career as a Professor of Reproductive Physiology, Bob published over 300 articles and lectured extensively both nationally and internationally. He earned numerous research awards, including LSU Research Master in 1990, the USDA Distinguished Researcher Award in 1992, and the highest LSU honor, a Boyd Professorship, in 1996. - Publisher's note
Thanks to our Referees
Reproductive BioMedicine OnlineVol. 32Issue 1vi–viiPublished in issue: January, 2016Cited in Scopus: 0At the time of going to press, the following people have completed reviews for articles submitted for publication between 1 November 2014 and 1 November 2015. - Editorial
What do we know about endometrial receptivity in women with endometriosis? A molecular perspective
Reproductive BioMedicine OnlineVol. 31Issue 5p581–583Published in issue: November, 2015- Signe Altmäe
- Lusine Aghajanova
Cited in Scopus: 6Endometriosis is a relatively wide-spread benign but debilitating gynaecological disorder affecting women of reproductive age. Endometriosis develops following the implantation of endometrial tissue at ectopic locations, mainly peritoneal and on the surface of pelvic organs (Giudice, 2010). The prevalence of this disease varies from 4–50% in different populations (Cramer and Missmer, 2002; Eskenazi and Warner, 1997), and occurs in up to 50% of women with pelvic pain and/or infertility (Giudice, 2010; Meuleman et al., 2009). - Editorial
Meet our new Editor
Reproductive BioMedicine OnlineVol. 31Issue 5p584Published in issue: November, 2015- Mina Alikani
Cited in Scopus: 3Dr Mina Alikani PhD is a Clinical Embryologist, currently working as a Laboratory Director and consultant in New York, USA. Her interest in this field was piqued in 1978, with the announcement of the world's first IVF birth. Having recently immigrated to the United States, she entered university, choosing biology as her major. Mina's early enthusiasm for developmental biology and embryology led her to the laboratories of Professor Lajos Pikó at the local Veteran's Administration Hospital, in Northridge, Southern California, where, as a young volunteer, she learned how to work with mice and isolate and culture early mouse embryos. - Editorial
Meet our new editor
Reproductive BioMedicine OnlineVol. 31Issue 6p717Published online: October 26, 2015- Juan A Garcia-Velasco
Cited in Scopus: 3Professor Juan A Garcia-Velasco MD PhD completed his medical training at Complutense University in Madrid, Spain in 1990 and his residency training in Obstetrics and Gynecology at La Paz Hospital, Madrid, Spain in 1995. He then joined Instituto Valenciano de Infertilidad (IVI) for a year in its early days (1996), followed immediately by a Fellowship in Reproductive Endocrinology and Infertility at Yale University, USA, where he worked under the guidance of Professor Aydin Arici (1997–1998). There he became enthusiastic about the relevance of molecular biology to human reproduction, and did extensive research in the field of cell adhesion and endometriosis. - Commentary
Baby factories taint surrogacy in Nigeria
Reproductive BioMedicine OnlineVol. 32Issue 1p6–8Published online: October 14, 2015- Olusesan Ayodeji Makinde
- Olufunmbi Olukemi Makinde
- Olalekan Olaleye
- Brandon Brown
- Clifford O. Odimegwu
Cited in Scopus: 11The practice of reproductive medicine in Nigeria is facing new challenges with the proliferation of ‘baby factories’. Baby factories are buildings, hospitals or orphanages that have been converted into places for young girls and women to give birth to children for sale on the black market, often to infertile couples, or into trafficking rings. This practice illegally provides outcomes (children) similar to surrogacy. While surrogacy has not been well accepted in this environment, the proliferation of baby factories further threatens its acceptance. - Commentary
Implementation of cleanroom technology in reproductive laboratories: the question is not why but how
Reproductive BioMedicine OnlineVol. 32Issue 1p9–11Published online: October 13, 2015- Sandro C. Esteves
- Fabiola C. Bento
Cited in Scopus: 7Two articles recently published in Reproductive BioMedicine Online described how fertility centres in the USA and Brazil implemented air quality control to newly designed facilities. In both case scenarios, a highly efficient air filtration was achieved by installing a centred system supplying filtered air to the IVF laboratory and other critical areas, combining air particulate and volatile organic compound (VOC) filtration. Evaluating retrospective data of over 3000 cycles from both centres, live birth rates were increased by improvements in air quality and laboratory environment. - Article
Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome
Reproductive BioMedicine OnlineVol. 31Issue 6p790–798Published online: September 18, 2015- Chun Yuan
- Chao Gao
- Yi Qian
- Ying Liu
- Shi-Wen Jiang
- Yugui Cui
- and others
Cited in Scopus: 11One characteristic of polycystic ovary syndrome (PCOS) is hyperandrogenism, which may be related to the activity of androgen receptor (AR). This study was designed to investigate the polymorphism of CAG and GGN repeats in the AR gene in women with PCOS. The frequency distributions of CAG and GGN repeat alleles, as well as their X-inactivation patterns, were compared between 76 age-matched normal women (control group) and 80 women with PCOS (PCOS group). The expression of AR mRNA in the ovarian tissues of seven patients with PCOS and five normal women was also tested using real-time quantitative PCR. - Review
The place of reconstructive tubal surgery in the era of assisted reproductive techniques
Reproductive BioMedicine OnlineVol. 31Issue 6p722–731Published online: September 18, 2015- Victor Gomel
Cited in Scopus: 15Assisted reproductive techniques yield high rates of success for women with tubal factor infertility. Because they are potentially effective for all categories of infertility, for two decades, clinical and basic research in infertility has been focused on IVF techniques and outcomes, rather than developing surgical techniques or training infertility subspecialists in tubal microsurgery. Nonetheless, in comparison with IVF, reconstructive tubal surgery is inexpensive and offers multiple opportunities to attempt conception. - Article
A pilot study to evaluate a device for the intravaginal culture of embryos
Reproductive BioMedicine OnlineVol. 31Issue 6p732–738Published online: September 17, 2015- Frederic Mitri
- Navid Esfandiari
- Joan Coogan-Prewer
- Paul Chang
- Yaakov Bentov
- John McNaught
- and others
Cited in Scopus: 5The aim of this comparative randomized embryology trial was to determine if an intravaginal culture device (IVC) can provide acceptable embryo development compared with conventional IVF. Ten women between the ages of 27 and 37 years with an indication for IVF treatment were included in this study. After ovarian stimulation, oocytes were randomized to fertilization in the IVC device or using conventional IVF. Fertilization rates were higher in the IVF group compared with the IVC device (68.7% ± 36 % versus 40.7% ± 27%), respectively, whereas cleavage rates were similar (93% ± 1.5% versus 97% ± 6%) for both groups. - Article
What's in a name? Variations in terminology of third-party reproduction
Reproductive BioMedicine OnlineVol. 31Issue 6p805–814Published online: September 15, 2015- Diane Beeson
- Marcy Darnovsky
- Abby Lippman
Cited in Scopus: 19The terminology used to discuss third-party reproduction, as with other new biomedical processes, can ease or impede communication and even influence behaviour. In an effort to sensitize analysts and stakeholders to variations in terminology and to facilitate communication on issues arising from international surrogacy arrangements, this paper examines variations in terms used. We introduce some of the issues previously raised by scholars concerned with analysis of discourse related to third-party reproduction. - Article
Validation of next-generation sequencing for comprehensive chromosome screening of embryos
Reproductive BioMedicine OnlineVol. 31Issue 6p760–769Published online: September 9, 2015- Allen Kung
- Santiago Munné
- Brandon Bankowski
- Alison Coates
- Dagan Wells
Cited in Scopus: 89Massively parallel genome sequencing, also known as next-generation sequencing (NGS), is the latest approach for preimplantation genetic diagnosis. The purpose of this study was to determine whether NGS can accurately detect aneuploidy in human embryos. Low coverage genome sequencing was applied to trophectoderm biopsies of embryos at the blastocyst stage of development. Sensitivity and specificity of NGS was determined by comparison of results with a previously validated platform, array-comparative genomic hybridization (aCGH). - Letter
Response: transplantation of ovarian tissue to postpone menopause – is it really more advantageous for women's health than menopause hormone therapy?
Reproductive BioMedicine OnlineVol. 31Issue 6p828Published online: September 2, 2015- Claus Yding Andersen
- Stine Gry Kristensen
Cited in Scopus: 1We want to thank Von Wolff and colleagues for their correspondence (von Wolff et al., 2015) concerning our recent paper (Yding Andersen and Kristensen, 2015) in which we describe a novel way of postponing menopause by transplanting the woman's own ovarian tissue cryostored during earlier reproductive years. Freezing of ovarian tissue is now technically available and increasingly used in connection with fertility preservation for young women receiving gonadotoxic treatment. The question posed is whether it is advisable to also use this technique for postponing menopause? - Letter
Transplantation of ovarian tissue to postpone menopause – is it really more advantageous for women's health than menopause hormone therapy?
Reproductive BioMedicine OnlineVol. 31Issue 6p827Published online: September 2, 2015- Michael von Wolff
- Ralf Dittrich
- Petra Stute
Cited in Scopus: 8The recent article in RBM Online entitled ‘Novel use of the ovarian follicular pool to postpone menopause and delay osteoporosis’ (Yding Andersen and Kristensen, 2015) addresses a very innovative topic. However there is one essential question which also needs to be addressed: is the physiological, endogenous hormone production induced by transplanted ovarian tissue – tissue menopause hormone therapy (THT) – more advantageous for women's health than a conventional menopause hormone therapy (MHT)? - Editorial
Live births following karyomapping – a “key” milestone in the development of preimplantation genetic diagnosis
Reproductive BioMedicine OnlineVol. 31Issue 3p307–308Published in issue: September, 2015- Alan H. Handyside
Cited in Scopus: 15Twenty-five years ago, during the early days of preimplantation genetic diagnosis (PGD), the use of the polymerase chain reaction (PCR) for single-cell genetics was in its infancy. Reamplification of short fragments of DNA with a second set of internal or “nested” primers for mutation detection was possible (Coutelle et al., 1989; Holding and Monk, 1989), but plagued with the problems of contamination and allele dropout (ADO). Separate clean-room facilities for sample preparation were therefore essential. - Letter
HFEA response to ‘A plea for caution and more research in the “experimental” use of ionophores in ICSI’
Reproductive BioMedicine OnlineVol. 31Issue 6p829–830Published online: August 26, 2015- Peter Thompson
Cited in Scopus: 3I am writing in response to the recent article in Reproductive Biomedicine Online, by van Blerkhom et al. (2015), which helpfully highlights the work of the Human Fertilisation and Embryology Authority's (HFEA) Scientific and Clinical Advances Advisory Committee (SCAAC) in this area but appears to misunderstand the committee's role. - CommentaryOpen Access
Cryopreservation and transplantation of ovarian tissue exclusively to postpone menopause: technically possible but endocrinologically doubtful
Reproductive BioMedicine OnlineVol. 31Issue 6p718–721Published online: August 21, 2015- Michael von Wolff
- Petra Stute
Cited in Scopus: 12Transplantation of cryopreserved ovarian tissue has been shown to induce pregnancies and puberty successfully. Therefore, using cryopreserved ovarian tissue to postpone menopause (tissue hormone therapy [THT]) seems to be an interesting option to avoid conventional menopause hormone therapy (MHT). Pregnancy induction and replacing MHT by THT, however, are completely different topics as different requirements need to be met. First, MHT requires long-lasting and continuous hormone production. It still needs to be proven if the transplanted tissue is active for at least 5 years with a continuous follicle growth to avoid phases with low oestrogen production, which would otherwise cause menopausal symptoms and could reduce the postulated benefit for women's health. - ReviewOpen Access
Non-invasive assessment of in-vitro embryo quality to improve transfer success
Reproductive BioMedicine OnlineVol. 31Issue 5p585–592Published online: August 12, 2015- Tina Rødgaard
- Peter M.H. Heegaard
- Henrik Callesen
Cited in Scopus: 71Although IVF has been performed routinely for many years to help couples with fertility problems and in relation to modern breeding of farm animals, pregnancy rates after transfer to a recipient have not improved during the last decade. Early prediction of the viability of in-vitro developed embryos before the transfer to a recipient still remains challenging. Presently, the predominant non-invasive technique for selecting viable embryos is based on morphology, where parameters such as rates of cleavage and blastocyst formation as well as developmental kinetics are evaluated mostly subjectively. - Review
Paternal obesity negatively affects male fertility and assisted reproduction outcomes: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 31Issue 5p593–604Published online: August 10, 2015- Jared M. Campbell
- Michelle Lane
- Julie A. Owens
- Hassan W. Bakos
Cited in Scopus: 176This systematic review investigated the effect of paternal obesity on reproductive potential. Databases searched were Pubmed, Ovid, Web of Science, Scopus, Cinahl and Embase. Papers were critically appraised by two reviewers, and data were extracted using a standardized tool. Outcomes were: likelihood of infertility, embryo development, clinical pregnancy, live birth, pregnancy viability, infant development, sperm; concentration, morphology, motility, volume, DNA fragmentation, chromatin condensation, mitochondrial membrane potential (MMP), and seminal plasma factors. - Letter
Accidentally delayed oocyte pickup – a challenge to the current paradigm
Reproductive BioMedicine OnlineVol. 31Issue 5p715–716Published online: August 4, 2015- Izhar Ben-Shlomo
- Johnny S. Younis
Cited in Scopus: 0Textbooks indicate that human ovulation occurs 38–39 hours after the administration of human chorionic gonadotrophin (HCG) in the setting of IVF. This known wisdom leads to the current practice of oocyte retrieval no later than 37 hours after HCG administration. The issue of the timing of HCG administration in relation to follicular size and hormonal response has received much attention (Chen et al., 2014), whereas only a few studies have been performed to examine the difference between the retrieval of oocytes earlier than 36 h following HCG administration, or later than 36 h but prior to 38 h (Garor et al., 2015; Raziel et al., 2006). - Editorial
Deep impact: sequencing embryo biopsy specimens at increasing depth
Reproductive BioMedicine OnlineVol. 31Issue 1p1–3Published in issue: July, 2015- Katharina Spath
- Dagan Wells
Cited in Scopus: 1Despite major advances in assisted reproductive technologies (ART), it remains the case that more than half of all IVF treatments do not ultimately result in the birth of a child. It is clear that the majority of embryos created through IVF are not capable of producing a viable pregnancy, with most failing to implant in the uterus or miscarrying soon afterwards (Fragouli et al., 2013). - Editorial
Is there a clinical future for GV manipulation?
Reproductive BioMedicine OnlineVol. 31Issue 1p4–5Published in issue: July, 2015- Henry Malter
- Jacques Cohen
Cited in Scopus: 0In this issue of RBMOnline, Zhang and Liu present their latest work involving mammalian germinal vesicle (GV) transfer (Zhang and Liu, 2015). This study extends the prior work of these authors and others in examining this technique (Liu et al., 2003; Takeuchi et al., 2001; Zhang et al., 1999). One finding of developmental interest is the observation that when reciprocal GV transfers between human and mouse oocytes were performed, the maturation process and spindle formation followed the expected form of the species donating the ooplast. - Review
Spermatogenesis, DNA damage and DNA repair mechanisms in male infertility
Reproductive BioMedicine OnlineVol. 31Issue 3p309–319Published online: June 19, 2015- Sezgin Gunes
- Maha Al-Sadaan
- Ashok Agarwal
Cited in Scopus: 125Spermatogenesis is a complex process of proliferation and differentiation during male germ cell development involving mitosis, meiosis and spermiogenesis. Endogenous and exogenous physical, chemical and biological sources modify the genome of spermatozoa. The genomic integrity and stability of the sperm is protected by DNA repair mechanisms. In the male germline cells, DNA repair mechanisms include nucleotide excision repair, base excision repair, DNA mismatch repair, double strand break repair and post-replication repair. - Review
The codon 72 polymorphism of the TP53 gene and endometriosis risk: a meta-analysis
Reproductive BioMedicine OnlineVol. 31Issue 3p320–326Published online: June 8, 2015- Yi Feng
- Yuan-Yuan Wu
- Li Li
- Zhi-Juan Luo
- Zhong Lin
- Ying-Hui Zhou
- and others
Cited in Scopus: 5Endometriosis is a chronic, inflammatory and common gynaecological disease. This study investigated the association between TP53 codon 72 polymorphism and the risk of endometriosis. A search for relevant articles was conducted in PubMed, Embase, CNKI, Wanfang, Weipu databases and Google Scholar. The strength of the relationships between TP53 codon 72 polymorphism and the risk of endometriosis was assessed by odds ratios (OR) and with 95% confidence intervals (CI). Sixteen case–control studies in 15 articles were included. - Letter
Response: Another consideration in minilaparotomy for myomectomy
Reproductive BioMedicine OnlineVol. 31Issue 3p444Published online: May 28, 2015- Stefano Palomba
- Giovanni Battista La Sala
Cited in Scopus: 1First of all we would like to thank Dr Kim and colleagues for their interest in our article (Palomba et al., 2015) and for their comments. In common with all papers submitted for publication in peer-reviewed journals, the published version of our paper incorporates suggestions and feedback received from referees. Thanks to the advice of two independent and, we assume, suitably qualified referees, we structured the data analysis and the discussion so that our article was well balanced with respect to different surgical techniques for myomectomy. - Letter
Another consideration in minilaparotomy for myomectomy
Reproductive BioMedicine OnlineVol. 31Issue 3p443Published online: May 28, 2015- Tae-Hee Kim
- Hae-Hyeog Lee
- Jun-Mo Kim
- Yeon-Suk Kim
Cited in Scopus: 1When we read the recent article by Palomba and colleagues (Palomba et al., 2015), we found that their systematic review did not compare all the risks and benefits of minilaparotomy versus laparoscopic minimally invasive surgery for myomectomy. Gynecologists are interested in surgical techniques for treatment of uterine disorders (Jeong, 2014), and should consider the advantages and safety of minilaparotomy for myomectomy. When laparoscopy-assisted hysterectomy was developed, gynecologists compared laparoscopy and laparotomy for hysterectomy. - Letter
To pill or not to pill in GnRH-antagonist cycles: still an open debate
Reproductive BioMedicine OnlineVol. 31Issue 3p445Published online: May 27, 2015- Juan A Garcia-Velasco
- Human Fatemi
Cited in Scopus: 1We read with interest the commentary by Griesinger and colleagues (Griesinger et al., 2015) concerning our recent mini-review in RBMOnline (Garcia-Velasco and Fatemi, 2015). Although we fully agree with the authors' last sentence (‘randomized studies should be performed to prove or disprove…’), we would like to clarify that apart from the well-known methodological explanations about pooling data in a meta-analysis, and even considering that it is the most convincing tool in evidence-based medicine, unless it is a solid study we cannot take it as the ultimate truth. - CommentaryOpen Access
To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!
Reproductive BioMedicine OnlineVol. 31Issue 1p6–8Published online: April 9, 2015- Georg Griesinger
- Christos A. Venetis
- Basil Tarlatzis
- Efstratios Michaelis Kolibianakis
Cited in Scopus: 14The planning of IVF treatment by scheduling menstruation and hence initiation of ovarian stimulation using sex-steroid pre-treatment is commonly used. Pooling data from six randomized-controlled trials encompassing 1343 patients, with and without combined oral contraceptive pill pre-treatment, suggests that the ongoing pregnancy rate per randomized woman is significantly lower in patients with oral contraceptive pill pre-treatment (relative risk [RR]: 0.80, 95% confidence interval [CI]: 0.66–0.97; rate difference [RD]: −5%, 95% CI: −10% to −1%; fixed effects model). - Editorial
A plea for caution and more research in the ‘experimental’ use of ionophores in ICSI
Reproductive BioMedicine OnlineVol. 30Issue 4p323–324Published in issue: April, 2015- Jonathan van Blerkom
- Jacques Cohen
- Martin Johnson
Cited in Scopus: 32Other than the fear of a negative pregnancy outcome, fear of fertilization failure is probably one of the foremost motives for the growing practice of using ICSI, rather than conventional insemination, for all couples undergoing IVF. However, even with the insertion of a morphologically normal sperm from an individual of known fertility, there are instances, albeit relatively rare, where no fertilization occurs, as indicated by absent pronuclear formation. Artificial oocyte activation, aimed at obtaining at least one zygote, is considered when all mature oocytes are supposedly affected. - Review
Impact of ovarian endometrioma on ovarian responsiveness and IVF: a systematic review and meta-analysis
Reproductive BioMedicine OnlineVol. 31Issue 1p9–19Published online: March 21, 2015- Chun Yang
- Yuhong Geng
- Yanhui Li
- Chunyan Chen
- Ying Gao
Cited in Scopus: 57In this systematic review and meta-analysis, the effect of ovarian endometrioma on ovarian responsiveness to stimulation and on assisted reproduction outcomes was evaluated. Nine published studies (1039 cases) were included. The number of oocytes retrieved (mean difference [MD] −1.50; 95% CI, −2.84 to −0.15, P = 0.03), metaphase II (MII) oocytes retrieved (MD −3.61; 95% CI −4.44 to −2.78, P < 0.00001) and total embryos formed (MD −0.66; 95% CI −1.13 to −0.18, P = 0.007) were significantly lower in women with ovarian endometrioma than the control group. - Editorial
Oocyte donor information – how much is enough?
Reproductive BioMedicine OnlineVol. 30Issue 3p209–210Published in issue: March, 2015- John B. Appleby
- Sarah Franklin
Cited in Scopus: 1One of the most contested debates in the field of reproductive donation concerns the question of how much information about gamete donors should be provided to gamete recipients. Part of what makes this question challenging is that there is only a limited pool of empirical research to draw from when making evidence-based arguments in favour of one policy or practice of information provision over another. Analysis of this evidence is further complicated by the fact that more evidence exists about recipients of sperm donation than recipients of oocyte donation. - Review
Open versus closed systems for vitrification of human oocytes and embryos
Reproductive BioMedicine OnlineVol. 30Issue 4p325–333Published online: January 16, 2015- Gábor Vajta
- Laura Rienzi
- Filippo Maria Ubaldi
Cited in Scopus: 82Vitrification is now the dominant approach for cryopreservation of human oocytes and embryos; however, serious disagreement persists, particularly about biosafety issues. Techniques are categorized as either ‘open’ or ‘closed’ according to occurrence of direct contact between the medium and liquid nitrogen during cryopreservation. Advocates of closed systems emphasize the potential danger of disease transmission mediated through liquid nitrogen, and praise the safety of their approach; those who use the open systems refer to the lack of evidence of disease transmission and regard their systems as more consistent and efficient. - Mini-Review
The oviduct: a neglected organ due for re-assessment in IVF
Reproductive BioMedicine OnlineVol. 30Issue 3p233–240Published online: December 5, 2014- Yves Ménézo
- Pierre Guérin
- Kay Elder
Cited in Scopus: 29The oviduct has long been considered a ‘pipeline’, a tube allowing transit of spermatozoa and embryos; this perspective has been reinforced by the success of human IVF. Evidence accumulated over several decades, however, indicates that embryos can modulate the metabolism of tubal cells in their environment. Human IVF culture media is based on formulations that pass mouse embryo assays as quality control: the requirements of mouse embryos differ from those of human embryos, and therefore conditions for human IVF are far removed from the natural environment of the oviduct. - Young investigator review
Repro-sexual intersections: sperm donation, HIV prevention and the public interest in semen
Reproductive BioMedicine OnlineVol. 30Issue 3p211–219Published online: December 1, 2014- Robert Pralat
Cited in Scopus: 7In the scientific literature on fertility and assisted reproduction, and in the corresponding area of clinical practice, increasing attention has been paid to two groups: people living with the human immunodeficiency virus (HIV) and gay men. However, research on fertility in the context of HIV focuses almost exclusively on heterosexual couples, whereas studies on non-heterosexual reproduction rarely mention HIV, despite the fact that, in many western countries, HIV prevalence among men who have sex with men is higher than ever before and men who have sex with men are the only group in which new HIV infections are on the rise. - Review
Adenomyosis: a life-cycle approach
Reproductive BioMedicine OnlineVol. 30Issue 3p220–232Published online: November 20, 2014- Giuseppe Benagiano
- Ivo Brosens
- Marwan Habiba
Cited in Scopus: 49The life-cycle approach to endometriosis highlighted unexpected features of the condition; the same approach was therefore applied to gain insight into the clinical features of adenomyosis and to draw a comparison with endometriosis. This is possible today thanks to new imaging techniques enabling non-invasive diagnosis of adenomyosis. The specificity and sensitivity of magnetic resonance imaging and transvaginal ultrasound remain uncertain. Unlike endometriosis, little information is available on the presence of classic adenomyosis in adolescents, except for rare cystic forms that may not represent the true disease. - CommentaryOpen Access
Implications of the legalization of non-commercial surrogacy for local kinship and motherhood in Vietnamese society
Reproductive BioMedicine OnlineVol. 30Issue 2p113–114Published online: November 7, 2014- Yuri Hibino
Cited in Scopus: 3Until recently, surrogacy was banned in Vietnam for all cases. The government, however, has altered its position on reproductive technology and will soon legalize non-commercial surrogacy among relatives. Motherhood is highly venerated in Vietnamese society and, under this local kinship conception, gestational process is of paramount importance in establishing a connection between the fetus and the woman. The implications of this new government decision for local kinship, motherhood and the individuals concerned will be discussed. - Article
Reporting of embryo transfer methods in IVF research: a cross-sectional study
Reproductive BioMedicine OnlineVol. 30Issue 2p137–143Published online: November 5, 2014- Pietro Gambadauro
- Ramesan Navaratnarajah
Cited in Scopus: 7If we accept that reproducibility is one of the principles of the scientific method (Siegel, 2011), then reporting the methods of research is equally important as disseminating its results. A good description of a study's methodology allows others to replicate the experiment accurately and verify previous findings. Current research, however, shows that scientific reporting can often be inadequate, even in the case of high-quality studies such as randomized controlled trials (Péron et al., 2012; Turner et al., 2012; Wang et al., 2011). - Article
No evidence of association between blastocyst aneuploidy and morphokinetic assessment in a selected population of poor-prognosis patients: a longitudinal cohort study
Reproductive BioMedicine OnlineVol. 30Issue 1p57–66Published online: October 4, 2014- L. Rienzi
- A. Capalbo
- M. Stoppa
- S. Romano
- R. Maggiulli
- L. Albricci
- and others
Cited in Scopus: 88Recent studies involving a limited number of patients have indicated a correlation between aneuploidy and various morphokinetic parameters during preimplantation development. The results among different groups, however, have been inconsistent in identifying the parameters that are able to predict chromosomal abnormalities. The aim of this study was to investigate whether aneuploidy of human blastocysts was detectable by specific morphokinetic parameters in patients at increased risk of aneuploidy because of advanced maternal age, history of unsuccessful IVF treatments, or both. - Review
Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies
Reproductive BioMedicine OnlineVol. 29Issue 6p665–683Published online: September 18, 2014- Christos A Venetis
- Stamatis P Papadopoulos
- Rudi Campo
- Stephan Gordts
- Basil C Tarlatzis
- Grigoris F Grimbizis
Cited in Scopus: 148The clinical implications of congenital uterine anomalies (CUA), and the benefits of hysteroscopic resection of a uterine septum, were evaluated. Studies comparing reproductive and obstetric outcome of patients with and without CUA and of patients who had and had not undergone hysteroscopic resection of a uterine septum, were evaluated. Meta-analysis of studies indicated that the pregnancy rate was decreased in women with CUA (RR 0.85, 95% CI 0.73 to 1.00; marginally significant finding, P = 0.05). - Article
Effects of in-vitro or in-vivo matured ooplasm and spindle-chromosome complex on the development of spindle-transferred oocytes
Reproductive BioMedicine OnlineVol. 29Issue 6p708–716Published online: September 15, 2014- Chenhui Ding
- Tao Li
- Yanhong Zeng
- Pingping Hong
- Yanwen Xu
- Canquan Zhou
Cited in Scopus: 1To study the effects of in-vitro matured ooplasm and spindle-chromosome complex (SCC) on the development of spindle-transferred oocytes, reciprocal spindle transfer was conducted between in-vivo and in-vitro matured oocytes. The reconstructed oocytes were divided into four groups according to their different ooplasm sources and SCC, artificially activated and cultured to the blastocyst stage. Oocyte survival, activation and embryo development after spindle transfer manipulation were compared between groups. - Article
Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol)
Reproductive BioMedicine OnlineVol. 29Issue 6p684–691Published online: September 5, 2014- Yanping Kuang
- Qiuju Chen
- Qingqing Hong
- Qifeng Lyu
- Ai Ai
- Yonglun Fu
- and others
Cited in Scopus: 181Previous studies have shown that existing antral follicles in the luteal phase enable ovarian stimulation. In a pilot study, the efficacy of double stimulations during the follicular and luteal phases in women with poor ovarian response was explored (defined according to the Bologna criteria). Thirty-eight women began with mild ovarian stimulation. After the first oocyte retrieval, human menopausal gonadotrophin and letrozole were administrated to stimulate follicle development, and oocyte retrieval was carried out a second time when dominant follicles had matured.